STERIS plc (STE) - Total Assets
Based on the latest financial reports, STERIS plc (STE) holds total assets worth $10.59 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check STERIS plc (STE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
STERIS plc - Total Assets Trend (1991–2025)
This chart illustrates how STERIS plc's total assets have evolved over time, based on quarterly financial data. Check STERIS plc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
STERIS plc - Asset Composition Analysis
Current Asset Composition (March 2025)
STERIS plc's total assets of $10.59 Billion consist of 19.7% current assets and 80.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $171.70 Million | 1.7% |
| Accounts Receivable | $1.04 Billion | 10.3% |
| Inventory | $581.33 Million | 5.7% |
| Property, Plant & Equipment | $2.11 Billion | 20.8% |
| Intangible Assets | $1.85 Billion | 18.3% |
| Goodwill | $4.10 Billion | 40.4% |
Asset Composition Trend (1991–2025)
This chart illustrates how STERIS plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see STERIS plc (STE) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: STERIS plc's current assets represent 19.7% of total assets in 2025, a decrease from 81.8% in 1991.
- Cash Position: Cash and equivalents constituted 1.7% of total assets in 2025, down from 6.8% in 1991.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 6.0% in 1991.
- Asset Diversification: The largest asset category is goodwill at 40.4% of total assets.
STERIS plc Competitors by Total Assets
Key competitors of STERIS plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥2.53 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
STERIS plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.48 | 2.13 | 2.10 |
| Quick Ratio | 1.75 | 1.40 | 1.55 |
| Cash Ratio | 0.46 | 0.17 | 0.00 |
| Working Capital | $1.36 Billion | $1.01 Billion | $633.83 Million |
STERIS plc - Advanced Valuation Insights
This section examines the relationship between STERIS plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.84 |
| Latest Market Cap to Assets Ratio | 1.96 |
| Asset Growth Rate (YoY) | -8.3% |
| Total Assets | $10.15 Billion |
| Market Capitalization | $19.87 Billion USD |
Valuation Analysis
Above Book Valuation: The market values STERIS plc's assets above their book value (1.96x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: STERIS plc's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for STERIS plc (1991–2025)
The table below shows the annual total assets of STERIS plc from 1991 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $10.15 Billion | -8.29% |
| 2024-03-31 | $11.06 Billion | +2.23% |
| 2023-03-31 | $10.82 Billion | -5.27% |
| 2022-03-31 | $11.42 Billion | +73.76% |
| 2021-03-31 | $6.57 Billion | +21.18% |
| 2020-03-31 | $5.43 Billion | +6.95% |
| 2019-03-31 | $5.07 Billion | -2.45% |
| 2018-03-31 | $5.20 Billion | +5.60% |
| 2017-03-31 | $4.92 Billion | -7.89% |
| 2016-03-31 | $5.35 Billion | +154.66% |
| 2015-03-31 | $2.10 Billion | +11.25% |
| 2014-03-31 | $1.89 Billion | +7.16% |
| 2013-03-31 | $1.76 Billion | +25.28% |
| 2012-03-31 | $1.41 Billion | -1.47% |
| 2011-03-31 | $1.43 Billion | +15.20% |
| 2010-03-31 | $1.24 Billion | +1.76% |
| 2009-03-31 | $1.22 Billion | -1.80% |
| 2008-03-31 | $1.24 Billion | +2.49% |
| 2007-03-31 | $1.21 Billion | +1.70% |
| 2006-03-31 | $1.19 Billion | +0.27% |
| 2005-03-31 | $1.19 Billion | +11.00% |
| 2004-03-31 | $1.07 Billion | +19.35% |
| 2003-03-31 | $894.99 Million | +6.35% |
| 2002-03-31 | $841.57 Million | -0.40% |
| 2001-03-31 | $844.98 Million | -6.48% |
| 2000-03-31 | $903.57 Million | +4.34% |
| 1999-03-31 | $866.00 Million | +18.25% |
| 1998-03-31 | $732.33 Million | +35.74% |
| 1997-03-31 | $539.50 Million | -8.98% |
| 1996-03-31 | $592.70 Million | +979.60% |
| 1995-03-31 | $54.90 Million | +28.57% |
| 1994-03-31 | $42.70 Million | +38.19% |
| 1993-03-31 | $30.90 Million | +286.25% |
| 1992-03-31 | $8.00 Million | +81.82% |
| 1991-03-31 | $4.40 Million | -- |
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more